Answers are grounded in this paper and cite their sources.
The American Diabetes Association recommends continuous glucose monitoring (CGM) to assist people with diabetes in reaching glycemic targets. However, implementation of CGM into routine practice, especially for clinics caring for underserved populations, is not well described. This study assessed the impact of short-term CGM in combination with a pharmacist-led collaborative drug therapy management service on glycemic control in underserved people with diabetes. The pharmacist-led CGM program resulted in improved glycemic control in this population. Future studies should evaluate the scalability and sustainability of this model across diverse clinical practice settings.
No takes yet. Share an insight, caveat, or question.
Gee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: